Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis

被引:15
作者
Burudpakdee, Chakkarin [1 ,2 ]
Khan, Zeba M. [3 ]
Gala, Smeet [1 ]
Nanavaty, Merena [1 ]
Kaura, Satyin [3 ]
机构
[1] Market Access Solut LLC, Raritan, NJ USA
[2] Univ N Carolina, Charlotte, NC 28223 USA
[3] Celgene Corp, Summit, NJ USA
关键词
systematic literature review; informational; behavioral; patient interventions; RANDOMIZED CONTROLLED-TRIAL; MEDICATION ADHERENCE; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; MANAGEMENT PROGRAM; ULCERATIVE-COLITIS; INTERVENTIONS; OSTEOPOROSIS; THERAPY; NONADHERENCE;
D O I
10.2147/PPA.S77053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Patient adherence and persistence is important to improve outcomes in chronic conditions, including inflammatory and immunologic (I&I) diseases. Patient programs that aim at improving medication adherence or persistence play an essential role in optimizing care. This meta-analysis assessed the effectiveness of patient programs in the therapeutic area of I&I diseases. Methods: A global systematic literature review was conducted with inclusion criteria of: patient programs in I&I diseases; published in English language between January 2008 and September 2013; and reporting measures of adherence or persistence, including medication possession ratio >80% and persistence rate. A meta-analysis was performed using a random effects model. Subgroup analyses based on the type of program was performed whenever feasible. Results: Of 67 studies reviewed for eligibility, a total of 17 studies qualified for inclusion in the meta-analysis. Overall, patient programs increased adherence (odds ratio [OR]=2.48, 95% confidence interval [CI]=1.68-3.64, P<0.00001) as compared with standard of care. Combination patient programs that used both informational and behavioral strategies were superior in improving adherence (OR=3.68, 95% CI=2.20-6.16, P<0.00001) compared with programs that used only informational (OR=2.16, 95% CI=1.36-3.44, P=0.001) or only behavioral approaches (OR=1.85, 95% CI=1.00-3.45, P=0.05). Additionally, patients were more likely to be persistent (OR=2.26, 95% CI=1.16-4.39, P=0.02) in the intervention group as compared with the control group. Persistence (in days) was significantly (P=0.007) longer, by 42 additional days, in the intervention group than in the control group. Conclusions: Patient programs can significantly improve adherence as well as persistence in the therapeutic area of I&I diseases. Programs employing a multimodal approach are more effective in improving adherence than programs with informational or behavioral strategies alone. This in turn may improve patient outcomes.
引用
收藏
页码:435 / 448
页数:14
相关论文
共 35 条
[1]   Patients' problems with new medication for chronic conditions [J].
Barber, N ;
Parsons, J ;
Clifford, S ;
Darracott, R ;
Horne, R .
QUALITY & SAFETY IN HEALTH CARE, 2004, 13 (03) :172-175
[2]   Systematic Review and Metaanalysis of Patient Self-Report versus Trained Assessor Joint Counts in Rheumatoid Arthritis [J].
Barton, Jennifer L. ;
Criswell, Lindsey A. ;
Kaiser, Rachel ;
Chen, Yea-Hung ;
Schillinger, Dean .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) :2635-2641
[3]   Telephone nurse counseling for medication adherence in ulcerative colitis: A preliminary study [J].
Cook, Paul F. ;
Emiliozzi, Suzie ;
El-Hajj, Dana ;
McCabe, Mishcha M. .
PATIENT EDUCATION AND COUNSELING, 2010, 81 (02) :182-186
[4]   The epidemiology of autoimmune diseases [J].
Cooper, GS ;
Stroehla, BC .
AUTOIMMUNITY REVIEWS, 2003, 2 (03) :119-125
[5]   Medication compliance and persistence: Terminology and definitions [J].
Cramer, Joyce A. ;
Roy, Anuja ;
Burrell, Anita ;
Fairchild, Carol J. ;
Fuldeore, Mahesh J. ;
Ollendorf, Daniel A. ;
Wong, Peter K. .
VALUE IN HEALTH, 2008, 11 (01) :44-47
[6]   E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach [J].
Elkjaer, Margarita ;
Shuhaibar, Mary ;
Burisch, Johan ;
Bailey, Yvonne ;
Scherfig, Hanne ;
Laugesen, Birgit ;
Avnstrom, Soren ;
Langholz, Ebbe ;
O'Morain, Colm ;
Lynge, Elsebeth ;
Munkholm, Pia .
GUT, 2010, 59 (12) :1652-1661
[7]   Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions [J].
Fischer, Michael A. ;
Stedman, Margaret R. ;
Lii, Joyce ;
Vogeli, Christine ;
Shrank, William H. ;
Brookhart, M. Alan ;
Weissman, Joel S. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (04) :284-290
[8]   Osteoporosis, inflammation and ageing [J].
Ginaldi L. ;
Di Benedetto M.C. ;
De Martinis M. .
Immunity & Ageing, 2 (1)
[9]   Review article: medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies [J].
Hawthorne, A. B. ;
Rubin, G. ;
Ghosh, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) :1157-1166
[10]  
Haynes RB, 1996, LANCET, V348, P383